Maverick Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-29,594
| Closed | -$1.95M | – | 248 |
|
2024
Q3 | $1.95M | Buy |
+29,594
| New | +$1.95M | 0.04% | 125 |
|
2024
Q1 | – | Sell |
-2,977
| Closed | -$227K | – | 452 |
|
2023
Q4 | $227K | Sell |
2,977
-2,331
| -44% | -$178K | ﹤0.01% | 319 |
|
2023
Q3 | $368K | Buy |
5,308
+990
| +23% | +$68.6K | 0.01% | 201 |
|
2023
Q2 | $407K | Sell |
4,318
-2,815
| -39% | -$266K | 0.01% | 279 |
|
2023
Q1 | $590K | Buy |
7,133
+3,511
| +97% | +$290K | 0.01% | 210 |
|
2022
Q4 | $270K | Sell |
3,622
-10,616
| -75% | -$792K | 0.01% | 311 |
|
2022
Q3 | $1.18M | Buy |
+14,238
| New | +$1.18M | 0.03% | 126 |
|
2020
Q4 | – | Sell |
-15,652
| Closed | -$1.25M | – | 710 |
|
2020
Q3 | $1.25M | Sell |
15,652
-14,889
| -49% | -$1.19M | 0.02% | 223 |
|
2020
Q2 | $2.11M | Buy |
+30,541
| New | +$2.11M | 0.04% | 169 |
|
2018
Q4 | – | Sell |
-117,480
| Closed | -$6.82M | – | 272 |
|
2018
Q3 | $6.82M | Sell |
117,480
-188,040
| -62% | -$10.9M | 0.08% | 130 |
|
2018
Q2 | $14.8M | Buy |
305,520
+81,090
| +36% | +$3.93M | 0.17% | 61 |
|
2018
Q1 | $10.4M | Sell |
224,430
-13,950
| -6% | -$649K | 0.13% | 93 |
|
2017
Q4 | $8.96M | Buy |
238,380
+100,710
| +73% | +$3.78M | 0.11% | 66 |
|
2017
Q3 | $5.02M | Buy |
137,670
+36,630
| +36% | +$1.33M | 0.06% | 76 |
|
2017
Q2 | $3.98M | Buy |
101,040
+8,370
| +9% | +$330K | 0.05% | 64 |
|
2017
Q1 | $2.91M | Sell |
92,670
-22,650
| -20% | -$710K | 0.04% | 49 |
|
2016
Q4 | $3.6M | Buy |
115,320
+34,620
| +43% | +$1.08M | 0.05% | 34 |
|
2016
Q3 | $3.24M | Sell |
80,700
-16,200
| -17% | -$651K | 0.04% | 48 |
|
2016
Q2 | $3.22M | Buy |
+96,900
| New | +$3.22M | 0.04% | 43 |
|
2015
Q3 | – | Sell |
-11,760
| Closed | -$279K | – | 123 |
|
2015
Q2 | $279K | Hold |
11,760
| – | – | ﹤0.01% | 64 |
|
2015
Q1 | $279K | Buy |
+11,760
| New | +$279K | ﹤0.01% | 67 |
|